Option chain shows key data for Kaival Brands Innovations's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Kaival Brands Innovations.

Kaival Brands Innovations (NASDAQ:KAVL) Stock, Option Chain

Kaival Brands Innovations

Kaival Brands Innovations Group Inc is focused on growing and incubating innovative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.

Wall-Street-dall

Equities

News

Commodities

Intraday Update

Markets

Trading Ideas

BHVN

ELAB

FUFU

KAVL

MNSO

ZJYL

Dow Gains Over 50 Points; Elevai Labs Shares Plummet

wall-street-ai17

Eurozone

Crude Oil Down Over 1%; US Manufacturing PMI Falls In September

handshake merger

Movers

Kaival Brands stock is moving higher after the company and Delta Corp entered a merger and share exchange agreement.

What&#39;s Going On With Kaival Brands Stock Monday?

Kaival Brands Innovations Group, Inc. - Common Stock

Kaival Brands Innovations Group Inc

Events

NVDA

Live On Fox Business NVIDIA CEO Jensen Huang Discusses Earnings, Says "Our Pricing Is Always Value Based"

Guggenheim analyst Ali Faghri maintains AutoNation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>) with a Buy and lowers the price target from $190 to $189.

Price Target

Analyst Ratings

Guggenheim Maintains Buy on AutoNation, Lowers Price Target to $189

Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) has launched a long-awaited feature for Xbox Game Pass Ultimate members, allowing them to stream select games they already own via Xbox Cloud <a href="https://www.benzinga.com/general/gaming">Gaming. </a>
This <a href="https://www.benzinga.com/general/gaming/24/10/41318405/microsoft-to-test-cloud-gaming-for-owned-xbox-games-in-november-report">long-in-development addition</a> has been a goal since 2019, but its rollout faced delays due to the challenge of preparing infrastructure for thousands of titles.
<h3 class="wp-block-heading">A Promising Start, But Limited Scope</h3>
As of today, only 50 games are compatible with the feature, the company<a href="https://news.xbox.com/en-us/2024/11/20/stream-your-own-game-xbox-cloud-gaming-beta/"> announced</a> in a blog post. Despite the modest start, the lineup includes high-profile blockbusters like Baldur's Gate 3, Cyberpunk 2077, Star Wars Outlaws, and Call of Duty: Modern Warfare II, alongside beloved indie titles like Dredge, Phasmophobia, and The Plucky Squire.
See Also:<a href="https://www.benzinga.com/general/gaming/24/11/42098642/play-ps5-games-without-a-console-playstation-portal-adds-cloud-streaming"> Play PS5 Games Without A Console: PlayStation Portal Adds Cloud Streaming</a>
While this is just a fraction of the Xbox catalog, Microsoft has confirmed that the list will grow over time as partnerships expand globally. "Our library of cloud-playable titles will continue to grow," Microsoft stated.
<h3 class="wp-block-heading">Compatibility And Future Expansion</h3>
Currently, the feature supports streaming on TVs and browsers via devices such as tablets, smartphones, and Meta Quest headsets. However, console owners will need to wait until next year for functionality on Xbox consoles and the Xbox app on Windows.
The release coincides with Sony's expansion of its own cloud gaming offerings, highlighting the intensifying competition in the space. Xbox Cloud Gaming's new feature sets the stage for further innovations as Microsoft positions itself as a leader in cloud-based gaming.
<h3 class="wp-block-heading">How To Get Started</h3>
To stream your games:
<ol>
<li>On PC, smartphones, and tablets:
<ul>
<li>Use a supported browser like Microsoft Edge, Google Chrome, or Safari.</li>
<li>Visit <a href="https://xbox.com/play">xbox.com/play</a>.</li>
<li>Sign into your Xbox Game Pass Ultimate account.</li>
<li>Look for the "Stream your own game" section and start playing.</li>
</ul>
</li>
<li>On TVs and VR headsets:
<ul>
<li>Download the Xbox app on supported devices.</li>
<li>Pair a compatible Bluetooth controller, such as the Xbox Wireless Controller or PlayStation DualSense.</li>
</ul>
</li>
</ol>
<h3 class="wp-block-heading">Over 50 Games Ready To Play</h3>
Here's the full list of titles you can stream starting today:
<ul>
<li>Animal Well</li>
<li>Assassin's Creed Mirage</li>
<li>Avatar: Frontiers of Pandora</li>
<li>Balatro</li>
<li>Baldur's Gate 3</li>
<li>Banishers: Ghosts of New Eden</li>
<li>Call of Duty: Modern Warfare II (2022)</li>
<li>The Casting of Frank Stone</li>
<li>Cyberpunk 2077</li>
<li>Dragon Quest III HD-2D Remake</li>
<li>Dredge</li>
<li>Dying Light 2 Stay Human</li>
<li>Farming Simulator 25</li>
<li>Fear the Spotlight</li>
<li>Final Fantasy XIV Online</li>
<li>Final Fantasy</li>
<li>Final Fantasy II</li>
<li>Final Fantasy III</li>
<li>Final Fantasy IV</li>
<li>Final Fantasy V</li>
<li>Final Fantasy VI</li>
<li>Hades</li>
<li>Harry Potter: Quidditch Champions</li>
<li>High On Life</li>
<li>Hitman World of Assassination</li>
<li>Hogwarts Legacy</li>
<li>House Flipper 2</li>
<li>Kena: Bridge of Spirits</li>
<li>Lego Harry Potter Collection</li>
<li>Life is Strange: Double Exposure</li>
<li>Metro Exodus</li>
<li>Mortal Kombat 1</li>
<li>NBA 2K25</li>
<li>PGA Tour 2K23</li>
<li>Phasmophobia</li>
<li>Prince of Persia: The Lost Crown</li>
<li>Rust Console Edition</li>
<li>7 Days to Die</li>
<li>Star Wars Outlaws</li>
<li>Stray</li>
<li>The Crew Motorfest</li>
<li>The Outlast Trials</li>
<li>The Plucky Squire</li>
<li>The Witcher 3: Wild Hunt</li>
<li>Tom Clancy's The Division 2</li>
<li>TopSpin 2K25</li>
<li>Undertale</li>
<li>Visions of Mana</li>
<li>Warhammer 40,000: Space Marine 2</li>
<li>WWE 2K24</li>
</ul>
Read Next: 
<a href="https://www.benzinga.com/general/gaming/24/11/41948549/xbox-handheld-a-few-years-out-says-microsoft-gaming-ceo-hints-at-cross-platform-games-new-acquisitions">Xbox Handheld &#8216;A Few Years Out,&#8217; Says Microsoft Gaming CEO; Hints At Cross-Platform Games, New Acquisitions</a>
Image credits: Shutterstock.

Gaming

General

MSFT

Xbox Cloud Gaming Now Lets You Stream Owned Games: Here's How It Works

Insider Trades

SEC Form 4 Filing Shows AIM ImmunoTech CEO And Director Thomas K. Equels Purchases 85,000 Shares At An Average Price Of $0.20

Whales with a lot of money to spend have taken a noticeably bullish stance on Burlington Stores.
Looking at options history for Burlington Stores (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>) we detected 10 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 30% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $224,965 and 6, calls, for a total amount of $2,687,578.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $247.5 to $280.0 for Burlington Stores over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Burlington Stores options trades today is 406.43 with a total volume of 6,960.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Burlington Stores's big money trades within a strike price range of $247.5 to $280.0 over the last 30 days.
<h3>Burlington Stores Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732208641_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BURL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$22.7</td>
<td>$21.4</td>
<td>$22.09</td>
<td>$260.00</td>
<td>$1.4M</td>
<td align="right">900</td>
<td>674</td>
</tr>
<tr>
<td>BURL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$12.7</td>
<td>$11.6</td>
<td>$12.15</td>
<td>$280.00</td>
<td>$815.5K</td>
<td align="right">487</td>
<td>922</td>
</tr>
<tr>
<td>BURL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$12.2</td>
<td>$11.8</td>
<td>$11.8</td>
<td>$280.00</td>
<td>$295.0K</td>
<td align="right">487</td>
<td>250</td>
</tr>
<tr>
<td>BURL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/22/24</td>
<td>$1.85</td>
<td>$1.75</td>
<td>$1.75</td>
<td>$260.00</td>
<td>$87.5K</td>
<td align="right">112</td>
<td>1.9K</td>
</tr>
<tr>
<td>BURL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/22/24</td>
<td>$2.0</td>
<td>$1.8</td>
<td>$1.8</td>
<td>$260.00</td>
<td>$78.6K</td>
<td align="right">112</td>
<td>2.3K</td>
</tr>
</tbody>
</table>

<h3>About Burlington Stores</h3>
Burlington Stores Inc is off-price retailer offering an extensive selection of in-season, fashion-focused merchandise including: women's ready-to-wear apparel, menswear, youth apparel, baby, beauty, footwear, accessories, home, toys, gifts and coats. Company sell a broad selection of desirable, first-quality, current-brand, labeled merchandise acquired directly from nationally recognized manufacturers and other suppliers. Company sell product in category such as Ladies apparel, Accessories and shoes, Home, Mens apparel, Kids apparel and baby and Outerwear.
<h3>Where Is Burlington Stores Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 273,635, the BURL's price is up by 1.03%, now at $271.8. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 5 days.</li>
</ul>
<h3>What The Experts Say On Burlington Stores</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $280.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Neutral rating on Burlington Stores with a target price of $280. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Burlington Stores options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

BURL

Burlington Stores's Options Frenzy: What You Need to Know

Deep-pocketed investors have adopted a bullish approach towards Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in JNJ usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 21 extraordinary options activities for Johnson &amp; Johnson. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 47% leaning bullish and 47% bearish. Among these notable options, 9 are puts, totaling $347,775, and 12 are calls, amounting to $492,730.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $95.0 to $165.0 for Johnson &amp; Johnson during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Johnson &amp; Johnson's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Johnson &amp; Johnson's substantial trades, within a strike price spectrum from $95.0 to $165.0 over the preceding 30 days.
<h3>Johnson &amp; Johnson Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732208636_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$22.6</td>
<td>$22.25</td>
<td>$22.25</td>
<td>$135.00</td>
<td>$100.1K</td>
<td>121</td>
<td>1.0K</td>
</tr>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$22.5</td>
<td>$21.75</td>
<td>$22.35</td>
<td>$135.00</td>
<td>$84.8K</td>
<td>121</td>
<td>1.0K</td>
</tr>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$2.19</td>
<td>$1.9</td>
<td>$1.92</td>
<td>$165.00</td>
<td>$58.8K</td>
<td>1.2K</td>
<td>307</td>
</tr>
<tr>
<td>JNJ</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$9.7</td>
<td>$9.2</td>
<td>$9.2</td>
<td>$160.00</td>
<td>$45.9K</td>
<td>935</td>
<td>157</td>
</tr>
<tr>
<td>JNJ</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$9.2</td>
<td>$8.4</td>
<td>$9.2</td>
<td>$160.00</td>
<td>$45.9K</td>
<td>935</td>
<td>157</td>
</tr>
</tbody>
</table>

<h3>About Johnson &amp; Johnson</h3>
Johnson &amp; Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
After a thorough review of the options trading surrounding Johnson &amp; Johnson, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Johnson &amp; Johnson's Current Market Status</h3>
<ul>
<li>With a trading volume of 2,352,484, the price of JNJ is up by 1.08%, reaching $154.77.</li>
<li>Current RSI values indicate that the stock is may be approaching oversold.</li>
<li>Next earnings report is scheduled for 62 days from now.</li>
</ul>
<h3>Expert Opinions on Johnson &amp; Johnson</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $176.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Wolfe Research downgraded its action to Outperform with a price target of $190. 
&#x2A; An analyst from Guggenheim persists with their Neutral rating on Johnson &amp; Johnson, maintaining a target price of $162. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Johnson &amp; Johnson with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Spotlight on Johnson & Johnson: Analyzing the Surge in Options Activity

Investors with a lot of money to spend have taken a bullish stance on Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MS, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 9 options trades for Morgan Stanley.
This isn't normal.
The overall sentiment of these big-money traders is split between 55% bullish and 22%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $264,770, and 8, calls, for a total amount of $422,923.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $130.0 to $145.0 for Morgan Stanley over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Morgan Stanley's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Morgan Stanley's significant trades, within a strike price range of $130.0 to $145.0, over the past month.
<h3>Morgan Stanley Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732208631_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$8.35</td>
<td>$8.3</td>
<td>$8.3</td>
<td>$140.00</td>
<td>$264.7K</td>
<td align="right">306</td>
<td>320</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$2.39</td>
<td>$2.24</td>
<td>$2.37</td>
<td>$133.00</td>
<td>$118.4K</td>
<td align="right">225</td>
<td>2.0K</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>11/29/24</td>
<td>$2.46</td>
<td>$2.24</td>
<td>$2.33</td>
<td>$133.00</td>
<td>$81.7K</td>
<td align="right">225</td>
<td>1.5K</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/29/24</td>
<td>$2.02</td>
<td>$1.99</td>
<td>$1.99</td>
<td>$134.00</td>
<td>$53.3K</td>
<td align="right">533</td>
<td>783</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$4.7</td>
<td>$4.2</td>
<td>$4.2</td>
<td>$130.00</td>
<td>$42.0K</td>
<td align="right">592</td>
<td>103</td>
</tr>
</tbody>
</table>

<h3>About Morgan Stanley</h3>
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments with approximately 45% of net revenue from its institutional securities business, 45% from wealth management, and 10% from investment management. About 30% of its total revenue is from outside the Americas. The company had over $5 trillion of client assets as well as around 80,000 employees at the end of 2023.
Having examined the options trading patterns of Morgan Stanley, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Morgan Stanley's Current Market Status</h3>
<ul>
<li>Trading volume stands at 1,855,277, with MS's price up by 2.64%, positioned at $135.17.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 56 days.</li>
</ul>
<h3>What Analysts Are Saying About Morgan Stanley</h3>
1 market experts have recently issued ratings for this stock, with a consensus target price of $142.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo has elevated its stance to Equal-Weight, setting a new price target at $142. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Morgan Stanley options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Morgan Stanley Unusual Options Activity For November 21

Guggenheim analyst Robert Drbul maintains Target (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) with a Buy and lowers the price target from $180 to $145.

Guggenheim Maintains Buy on Target, Lowers Price Target to $145

Raymond James analyst John Freeman maintains Viper Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) with a Outperform and raises the price target from $58 to $62.

VNOM

Raymond James Maintains Outperform on Viper Energy, Raises Price Target to $62

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Hims & Hers Launches Meal Replacement Bars And Shakes To Enhance Personalized Weight Loss Plans, Offering Comprehensive Nutrition Support For Customers Starting At $110/Month

Agrify Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGFY#NASDAQ">AGFY</a>) announced Thursday that is has secured a $25.9 million non-brokered private placement.
<h3 class="wp-block-heading">What Happened</h3>
The company said it has entered into securities purchase agreements with institutional and accredited investors in a non-brokered private placement priced at $22.30 per share.
The placement is set to close on Thursday, Nov. 21, subject to customary closing conditions.
Benjamin Kovler, chairman and interim CEO, participated in the private placement to purchase 10,000 shares of common stock at $38.76.
The news comes on the heels of the company's board of directors having <a href="https://www.benzinga.com/markets/cannabis/24/11/41760263/marijuana-growing-solution-provider-agrify-gets-20m-boost-from-green-thumb-to-power-up-cannabis-">approved</a> a $20 million convertible secured note. Of that sum $10 million will be drawn upon at closing, from a wholly-owned subsidiary of Green Thumb Industries Inc., Agrify said in a press release.
Before this, the Green Thumb subsidiary acquired an ownership stake in Agrify through the purchase of common stock and warrants from its outgoing chairman and CEO Raymond Chang and outgoing director I-Tseng Jenny Chan.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/05/38876948/cannabis-cultivation-solutions-provider-agrify-and-californias-natures-miracle-sign-definitive-m">Cannabis Cultivation Solutions Provider Agrify And California&#8217;s Nature&#8217;s Miracle Sign Definitive Merger Deal</a>
<h3 class="wp-block-heading">Why It Matters</h3>
Agrify plans to use the proceeds from the private placement for general corporate purposes, including, among other things, working capital and business development. It intends to allocate capital to opportunities in the cannabis and hemp industries.
"This funding is a strong move for Agrify and our shareholders as we were able to raise approximately $26 million in a non-brokered deal (gross equals net)," Kovler said. "We plan to allocate this capital into opportunities within our circle of competence to benefit stockholders. We are excited about the opportunity set and current consumer trends in cannabis and hemp. The team continues to work hard to close the previously announced Señorita transaction, and it remains on track for closing at or around year-end."
Agrify reported its third quarter 2024 financial results on Nov. 14, revealing a $1.9 million revenue, down from $3.1 million a year ago. The company posted a net loss of $18.6 million, largely driven by a $15 million change in the <a href="https://www.benzinga.com/news/earnings/24/11/41998220/agrifys-q3-revenue-drop-18-6m-loss-amid-new-leadership">fair value of warrant liabilities.</a>
<h3 class="wp-block-heading">AGFY Price Action</h3>
Agrify's shares traded 25.15% lower at $29.01 per share at the time of writing on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/06/39271387/cannabis-cultivation-solutions-provider-agrify-announces-500k-turnkey-extraction-equipment-deal-">Cannabis Cultivation Solutions Provider Agrify Announces $500K Turnkey Extraction Equipment Deal With This NJ Co.</a></li>
</ul>

Cannabis

Financing

AGFY

NASDAQ-Traded Cannabis Co. Agrify Secures $25.9M Via Private Placement, Here's How They'll Spend It

Guggenheim analyst Joseph Osha maintains Shoals Technologies Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) with a Buy and lowers the price target from $8 to $7.

SHLS

Guggenheim Maintains Buy on Shoals Technologies Gr, Lowers Price Target to $7

Raymond James analyst Brian Peterson maintains Global E Online (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLBE#NASDAQ">GLBE</a>) with a Outperform and raises the price target from $41 to $55.

GLBE

Raymond James Maintains Outperform on Global E Online, Raises Price Target to $55

U.S. natural gas prices are on fire this month, surging by about 50% to reach $3.40 per million British thermal units as of Nov. 21, the highest level <a href="https://www.benzinga.com/24/11/42113449/natural-gas-prices-spike-to-over-1-year-highs-oil-surges-to-70-as-russia-fires-intercontinental-ballistic-missile-to-ukraine">in over a year.</a>
November is poised to mark the strongest surge in natural gas at the Henry Hub pricing point since July 2022, fueled by heightened geopolitical tensions, unseasonably cold U.S. weather and rising export demand.
For investors, this sharp price rebound has cast a spotlight on natural gas stocks poised to benefit from the renewed momentum in the natural gas markets.
<h1 class="wp-block-heading">Why Are Natural Gas Prices Spiking?</h1>
The price rally has been driven by a combination of factors:
<ul>
<li>Plunging Temperatures Across the U.S.: After a relatively warmer-than-average start to the winter, the situation has drastically changed over the past few weeks. The National Oceanic and Atmospheric Administration forecasts the first major snowfall of the season for parts of the central and northern Appalachians, with lower elevations in Pennsylvania and New York also bracing for accumulation. This colder weather has pushed demand for heating sharply higher.</li>
<li>Geopolitical Tensions Between Russia and Ukraine: Russia's launch of an intercontinental ballistic missile on Thursday, combined with Ukraine&#8217;s recent use of Western-made missiles to target Russian territory, has added a geopolitical risk premium to natural gas markets.</li>
<li>Supply Concerns in Europe: Austria&#8217;s OMV Group revealed earlier this month that it will stop receiving natural gas volumes from Russia&#8217;s Gazprom, reigniting fears of winter supply shortages in Europe and potentially shifting demand to the U.S. for liquefied natural gas (LNG) exports.</li>
</ul>
<h1 class="wp-block-heading">7 Natural Gas Stocks Benefiting From The Rally</h1>
As natural gas prices rally, several U.S. energy companies stand to gain from higher commodity prices and increased demand. Here are seven stocks to watch:
<h4 class="wp-block-heading">1. EQT Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQT#NYSE">EQT</a>)</h4>
EQT is the largest natural gas producer in the U.S., with operations in the Appalachian Basin. The company benefits directly from higher domestic gas prices.
Shares of EQT Corp. are up 30% month-to-date, on track for their strongest performing month since March 2022. 
<h4 class="wp-block-heading">2. ONEOK, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKE#NYSE">OKE</a>)</h4>
As a midstream operator, ONEOK processes and transports natural gas, profiting from higher pipeline volumes as demand increases.
Shares of ONEOK Inc. are up 19.6% in November, eyeing their best monthly performance since November 2020. 
<h4 class="wp-block-heading">3. Targa Resources Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRGP#NYSE">TRGP</a>)</h4>
Targa specializes in natural gas gathering and processing, positioning it to benefit from both domestic demand and export growth.
Targa shares have rallied 24% this month, on track to notch the 10th straight positive month and the strongest one in four years.
<h4 class="wp-block-heading">4. Kinder Morgan, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMI#NYSE">KMI</a>)</h4>
One of the largest pipeline operators in the U.S., Kinder Morgan&#8217;s infrastructure is critical for natural gas transportation across regions.
Kinder Morgan has seen its stock rally 16% in November, potentially positioned for the best month since November 2020. 
<h4 class="wp-block-heading">5. Antero Resources Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AR#NYSE">AR</a>)</h4>
Focused on natural gas and liquids production, Antero Resources has significant exposure to the Appalachia region, where colder weather is driving demand.
Shares of Antero Resources have soared 32% month-to-date, following a 9.7% drop in October. 
<h4 class="wp-block-heading">6. Cheniere Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNG#NYSE">LNG</a>)</h4>
As the top exporter of liquefied natural gas from the U.S., Cheniere benefits from global demand for natural gas, particularly in Europe.
Cheniere Energy has gained 16% thus far this month. 
<h4 class="wp-block-heading">7. Williams Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMB#NYSE">WMB</a>)</h4>
Williams operates natural gas infrastructure and transmission pipelines, playing a vital role in connecting supply to end markets.
Shares are up 13.6% in November, following a 14.7% surge in October. 
<h1 class="wp-block-heading">Chart: US Natural Gas Stocks Rallied In November</h1>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="501" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21105956/image-221-1024x501.png" alt="" class="wp-image-659155" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21105956/image-221-1024x501.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21105956/image-221-300x147.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21105956/image-221-768x376.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21105956/image-221-1536x752.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21105956/image-221.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h1 class="wp-block-heading">EIA Natural Gas Outlook: Winter Demand and LNG Exports To Support Prices</h1>
The EIA's latest Short-Term Energy Outlook (STEO) is bullish about near-term natural price gains, supported by robust winter demand and growing LNG exports.
With colder-than-expected weather forecasted for the season, the EIA has increased its consumption estimates, particularly in residential and commercial sectors where heating needs dominate. Residential and commercial demand is now expected to average 36 billion cubic feet per day (Bcf/d), representing a 4% increase from last winter.
In 2025, U.S. marketed natural gas production is projected to grow by 1%, with the Permian Basin leading the way with a 6% increase, followed by a 5% rise in output from the Eagle Ford region. 
The EIA anticipates Henry Hub natural gas prices — as tracked by the United States Natural Gas Fund LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNG#NYSE">UNG</a>) – to climb steadily in early 2025, averaging $2.80 per million British thermal units in the first quarter and $2.90/MMBtu for the entire year. This represents a significant 33% increase compared to the 2024 average of $2.20/MMBtu.
Liquefied natural gas exports are expected to play a critical role in driving demand next year, with exports projected to increase by nearly 2 Bcf/d in 2025. The growth in LNG capacity, coupled with sustained international demand, further strengthens the outlook for higher natural gas prices in the coming year.
<h1 class="wp-block-heading">Goldman Sachs Natural Gas Outlook: $4.00 Delayed Until 2026</h1>
Goldman Sachs offers a more cautious perspective on natural gas prices, citing delays in the construction and operation of new LNG export facilities across the Americas.
According to analyst Samantha Dart, these delays are expected to soften the trajectory of U.S. natural gas price increases and could hinder Europe's ability to replenish its gas storage levels for the 2025 season.
Goldman Sachs revised its 2025 Henry Hub price forecast downward to $3/MMBtu, from a previous estimate of $3.40/MMBtu.
The bank also pushed its projection for U.S. natural gas prices to hit $4/MMBtu to 2026, postponing it from the fourth quarter of 2025. 
The firm indicates that while slower U.S. LNG export growth might ease domestic price pressures temporarily, it poses challenges for Europe, which will have fewer LNG cargoes at its disposal to fill storage next summer. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42112078/international-criminal-court-issues-arrest-warrants-for-netanyahu-gallant">International Criminal Court Issues Arrest Warrants For Israeli Prime Minister Netanyahu, Gallant For War Crimes</a></li>
</ul>
Photo: Shutterstock

Large Cap

Mid Cap

Specialty ETFs

Global

ETFs

TRGP

7 US Natural Gas Stocks To Watch As Henry Hub Prices Surge 50% In November

<a href="https://hntrbrk.com/breaking-roblox-faces-undisclosed-probes-by-sec-enforcement-and-ftc-amid-hindenburg-accusations-of-inflated-key-metrics-for-wall-street-and-a-pedophile-hellscape-for-kids/" title="https://hntrbrk.com/breaking-roblox-faces-undisclosed-probes-by-sec-enforcement-and-ftc-amid-hindenburg-accusations-of-inflated-key-metrics-for-wall-street-and-a-pedophile-hellscape-for-kids/">https://hntrbrk.com/breaking-roblox-faces-undisclosed-probes-by-sec-enforcement-and-ftc-amid-hindenburg-accusations-of-inflated-key-metrics-for-wall-street-and-a-pedophile-hellscape-for-kids/</a>

Short Sellers

RBLX

Watching Roblox; Shares See A Spike In Volume To The Downside, Traders Circulate Report From HunterBrook Research

WIIM

GOOG

GOOGL

Alphabet shares are trading lower after the U.S. Department of Justice demanded that Google divest its Chrome browser.

IGIC

International General Insurance shares are trading higher after Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $130 price target.

Transdigm shares are trading lower following a report from The Bear Cave

Raymond James analyst John Freeman maintains Crescent Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRGY#NYSE">CRGY</a>) with a Strong Buy and raises the price target from $19 to $20.

CRGY

Raymond James Maintains Strong Buy on Crescent Energy, Raises Price Target to $20

DT Midstream shares are trading higher after Citigroup upgraded the stock from Neutral to Buy and raised its price target from $90 to $115.

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Kaival Brands Innovations&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/kavl-stock-quote/">KAVL</a>) stock is falling on Monday after the electronic nicotine delivery system company&rsquo;s shares <a href="https://investorplace.com/2024/06/why-is-kaival-brands-kavl-stock-up-286-today/">underwent a massive rally</a> on Friday.



Shares of KAVL stock rallied 338.2% on Friday without any clear news from the company. That brought with it heavy trading as almost 71 million shares changed hands that day. To put that number in perspective, Kaival Brands Innovations&rsquo; daily average trading volume is closer to 3.7 million shares.



One factor that may have been affecting KAVL stock is its low float. The company&rsquo;s float is only <a href="https://finance.yahoo.com/quote/KAVL/key-statistics">sitting at about 845,900 shares</a>. This opens it up to volatility alongside heavy trading.



On top of that, KAVL is a penny stock. That comes from its $17.063 million market capitalization. This is another factor that could affect its volatility.



<h2>KAVL Stock Movement Today</h2>



Considering its penny stock status, it makes sense that KAVL would give up some of its gains from Friday. It&rsquo;s also worth noting that it isn&rsquo;t seeing heavy trading today with only about 400,000 shares on the move this morning.



KAVL stock is down 32.7% as of Monday morning. The shares were up 30.7% year-to-date when markets last closed.



Investors will want to keep reading for all of the latest stock market stories!



We have all of the hottest stock market news available to investors on Monday! A few examples include what&rsquo;s going on with shares of ENDRA Life Sciences&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/ndra-stock-quote/">NDRA</a>) and Scinai Immunotherapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/scni-stock-quote/">SCNI</a>) stock, as well as the biggest pre-market stock movers this morning. All of that news is ready at the following links!



<h2>More Monday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/06/why-is-endra-life-sciences-ndra-stock-up-36-today/">Why Is ENDRA Life Sciences (NDRA) Stock Up 36% Today?</a></li>



<li><a href="https://investorplace.com/2024/06/why-is-scinai-immunotherapeutics-scni-stock-up-88-today/">Why Is Scinai Immunotherapeutics (SCNI) Stock Up 88% Today?</a></li>



<li><a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-june-17th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Monday</a></li>
</ul>On <a href="https://investorplace.com/stock-types/penny-stocks/">Penny Stocks</a> and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/why-is-kaival-brands-innovations-kavl-stock-down-33-today/">Why Is Kaival Brands Innovations (KAVL) Stock Down 33% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Kaival Brands Innovations (KAVL) Stock Down 33% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a hot topic on Thursday and we have all the hottest news behind these movements!



Moving stocks this morning are study data, acquisition updates, a secondary stock offering and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>SMX (Security Matters) (NASDAQ:<a href="https://investorplace.com/stock-quotes/smx-stock-quote/">SMX</a>) stock is rocketing more than 100% alongside heavy pre-market trading.</li>



<li>Tempest Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/tpst-stock-quote/">TPST</a>) shares are soaring over 50% <a href="https://www.nasdaq.com/press-release/tempest-report-new-data-global-randomized-combination-study-amezalpat-tpst-1120-first">with new study data</a>.</li>



<li>Reliance Global Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/reli-stock-quote/">RELI</a>) stock is surging close to 35% on <a href="https://www.stocktitan.net/news/RELI/reliance-global-group-provides-update-on-pending-spetner-swj01901tpjv.html">an acquisition update</a>.</li>



<li>Nexalin Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/nxl-stock-quote/">NXL</a>) shares are gaining more than 21% without any clear news this morning.</li>



<li>Molecular Partners (NASDAQ:<a href="https://investorplace.com/stock-quotes/moln-stock-quote/">MOLN</a>) stock is rising over 17% on Thursday morning.</li>



<li>Denali Capital (NASDAQ:<a href="https://investorplace.com/stock-quotes/deca-stock-quote/">DECA</a>) shares are increasing more than 17% in <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318402456&amp;type=PDF&amp;symbol=DECAU&amp;cdn=cb73376de3b0882ecdc7b6dd0bf51177&amp;companyName=Denali+Capital+Acquisition+Corp.+Unit&amp;formType=PRE+14A&amp;formDescription=Preliminary+proxy+statement+providing+notification+matters+to+be+brought+to+a+vote&amp;dateFiled=2024-06-18">shareholder meeting plans</a>.</li>



<li>Schmid Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/shmd-stock-quote/">SHMD</a>) stock is climbing over 16% today.</li>



<li>Presto Automation (NASDAQ:<a href="https://investorplace.com/stock-quotes/prst-stock-quote/">PRST</a>) shares are heading more than 16% higher this morning.</li>



<li>Talphera (NASDAQ:<a href="https://investorplace.com/stock-quotes/tlph-stock-quote/">TLPH</a>) stock is jumping over 15% without any obvious news to report.</li>



<li>Aslan Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/asln-stock-quote/">ASLN</a>) shares are up more than 14% on Thursday.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Avrobio (NASDAQ:<a href="https://investorplace.com/stock-quotes/avro-stock-quote/">AVRO</a>) stock is crashing over 91% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318400833&amp;type=PDF&amp;symbol=AVRO&amp;cdn=ca84ee38e74b0f6636bad1d41ecb78df&amp;companyName=AVROBIO+Inc.&amp;formType=8-K%2FA&amp;formDescription=%5BAmend%5DCurrent+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-18">merger and reverse stock split news</a>.</li>



<li>NLS Pharmaceutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/nlsp-stock-quote/">NLSP</a>) shares are plummeting more than 22% <a href="https://investorplace.com/2024/06/why-is-nls-pharmaceutics-nlsp-stock-up-163-today/">after a recent rally</a>.</li>



<li>Kaival Brands Innovations (NASDAQ:<a href="https://investorplace.com/stock-quotes/kavl-stock-quote/">KAVL</a>) stock is diving over 17% on Thursday.</li>



<li>1847 Holdings (NYSEMKT:<a href="https://investorplace.com/stock-quotes/efsh-stock-quote/">EFSH</a>) shares are taking a more than 17% beating on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318402194&amp;type=PDF&amp;symbol=EFSH&amp;cdn=8afe17ea6c0dfe97988938c03ada1ad9&amp;companyName=1847+Holdings+LLC&amp;formType=424B3&amp;formDescription=Prospectus+%5BRule+424%28b%29%283%29%5D&amp;dateFiled=2024-06-18">proposed secondary stock offering</a>.</li>



<li>La Rosa (NASDAQ:<a href="https://investorplace.com/stock-quotes/lrhc-stock-quote/">LRHC</a>) stock is tumbling over 16% after a <a href="https://www.nasdaq.com/press-release/la-rosa-holdings-corp-announces-plans-acquire-controlling-interest-red-door-title">recent rally on acquisition news</a>.</li>



<li>Huize (NASDAQ:<a href="https://investorplace.com/stock-quotes/huiz-stock-quote/">HUIZ</a>) shares are sliding more than 15% on <a href="https://www.nasdaq.com/press-release/huize-acquires-leading-vietnam-insurtech-platform-global-care-2024-06-20">an acquisition announcemcent</a>.</li>



<li>Actelis Networks (NASDAQ:<a href="https://investorplace.com/stock-quotes/asns-stock-quote/">ASNS</a>) stock is falling over 13% <a href="https://investorplace.com/2024/06/why-is-actelis-networks-asns-stock-up-144-today/">after a rally</a>.</li>



<li>N2OFF (NASDAQ:<a href="https://investorplace.com/stock-quotes/nito-stock-quote/">NITO</a>) shares are decreasing more than 13% <a href="https://www.nasdaq.com/press-release/n2off-save-foods-expanding-latin-america-new-purchase-order-peruvian-customer-2024-06">after a similar rally</a>.</li>



<li>Mustang Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/mbio-stock-quote/">MBIO</a>) stock is dropping over 13% <a href="https://investorplace.com/2024/06/why-is-mustang-bio-mbio-stock-up-347-today/">following a rally</a>.</li>



<li>Qualigen Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/qlgn-stock-quote/">QLGN</a>) shares close out our pre-market stock movers down 13% today.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-june-20th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a hot topic on Thursday and we have all the hottest news behind these movements!



Moving stocks this morning are study data, acquisition updates, a secondary stock offering and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>SMX (Security Matters) (NASDAQ:<a href="https://investorplace.com/stock-quotes/smx-stock-quote/">SMX</a>) stock is rocketing more than 100% alongside heavy pre-market trading.</li>



<li>Tempest Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/tpst-stock-quote/">TPST</a>) shares are soaring over 50% <a href="https://www.nasdaq.com/press-release/tempest-report-new-data-global-randomized-combination-study-amezalpat-tpst-1120-first">with new study data</a>.</li>



<li>Reliance Global Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/reli-stock-quote/">RELI</a>) stock is surging close to 35% on <a href="https://www.stocktitan.net/news/RELI/reliance-global-group-provides-update-on-pending-spetner-swj01901tpjv.html">an acquisition update</a>.</li>



<li>Nexalin Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/nxl-stock-quote/">NXL</a>) shares are gaining more than 21% without any clear news this morning.</li>



<li>Molecular Partners (NASDAQ:<a href="https://investorplace.com/stock-quotes/moln-stock-quote/">MOLN</a>) stock is rising over 17% on Thursday morning.</li>



<li>Denali Capital (NASDAQ:<a href="https://investorplace.com/stock-quotes/deca-stock-quote/">DECA</a>) shares are increasing more than 17% in <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318402456&amp;type=PDF&amp;symbol=DECAU&amp;cdn=cb73376de3b0882ecdc7b6dd0bf51177&amp;companyName=Denali+Capital+Acquisition+Corp.+Unit&amp;formType=PRE+14A&amp;formDescription=Preliminary+proxy+statement+providing+notification+matters+to+be+brought+to+a+vote&amp;dateFiled=2024-06-18">shareholder meeting plans</a>.</li>



<li>Schmid Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/shmd-stock-quote/">SHMD</a>) stock is climbing over 16% today.</li>



<li>Presto Automation (NASDAQ:<a href="https://investorplace.com/stock-quotes/prst-stock-quote/">PRST</a>) shares are heading more than 16% higher this morning.</li>



<li>Talphera (NASDAQ:<a href="https://investorplace.com/stock-quotes/tlph-stock-quote/">TLPH</a>) stock is jumping over 15% without any obvious news to report.</li>



<li>Aslan Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/asln-stock-quote/">ASLN</a>) shares are up more than 14% on Thursday.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Avrobio (NASDAQ:<a href="https://investorplace.com/stock-quotes/avro-stock-quote/">AVRO</a>) stock is crashing over 91% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318400833&amp;type=PDF&amp;symbol=AVRO&amp;cdn=ca84ee38e74b0f6636bad1d41ecb78df&amp;companyName=AVROBIO+Inc.&amp;formType=8-K%2FA&amp;formDescription=%5BAmend%5DCurrent+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-18">merger and reverse stock split news</a>.</li>



<li>NLS Pharmaceutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/nlsp-stock-quote/">NLSP</a>) shares are plummeting more than 22% <a href="https://investorplace.com/2024/06/why-is-nls-pharmaceutics-nlsp-stock-up-163-today/">after a recent rally</a>.</li>



<li>Kaival Brands Innovations (NASDAQ:<a href="https://investorplace.com/stock-quotes/kavl-stock-quote/">KAVL</a>) stock is diving over 17% on Thursday.</li>



<li>1847 Holdings (NYSEMKT:<a href="https://investorplace.com/stock-quotes/efsh-stock-quote/">EFSH</a>) shares are taking a more than 17% beating on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318402194&amp;type=PDF&amp;symbol=EFSH&amp;cdn=8afe17ea6c0dfe97988938c03ada1ad9&amp;companyName=1847+Holdings+LLC&amp;formType=424B3&amp;formDescription=Prospectus+%5BRule+424%28b%29%283%29%5D&amp;dateFiled=2024-06-18">proposed secondary stock offering</a>.</li>



<li>La Rosa (NASDAQ:<a href="https://investorplace.com/stock-quotes/lrhc-stock-quote/">LRHC</a>) stock is tumbling over 16% after a <a href="https://www.nasdaq.com/press-release/la-rosa-holdings-corp-announces-plans-acquire-controlling-interest-red-door-title">recent rally on acquisition news</a>.</li>



<li>Huize (NASDAQ:<a href="https://investorplace.com/stock-quotes/huiz-stock-quote/">HUIZ</a>) shares are sliding more than 15% on <a href="https://www.nasdaq.com/press-release/huize-acquires-leading-vietnam-insurtech-platform-global-care-2024-06-20">an acquisition announcemcent</a>.</li>



<li>Actelis Networks (NASDAQ:<a href="https://investorplace.com/stock-quotes/asns-stock-quote/">ASNS</a>) stock is falling over 13% <a href="https://investorplace.com/2024/06/why-is-actelis-networks-asns-stock-up-144-today/">after a rally</a>.</li>



<li>N2OFF (NASDAQ:<a href="https://investorplace.com/stock-quotes/nito-stock-quote/">NITO</a>) shares are decreasing more than 13% <a href="https://www.nasdaq.com/press-release/n2off-save-foods-expanding-latin-america-new-purchase-order-peruvian-customer-2024-06">after a similar rally</a>.</li>



<li>Mustang Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/mbio-stock-quote/">MBIO</a>) stock is dropping over 13% <a href="https://investorplace.com/2024/06/why-is-mustang-bio-mbio-stock-up-347-today/">following a rally</a>.</li>



<li>Qualigen Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/qlgn-stock-quote/">QLGN</a>) shares close out our pre-market stock movers down 13% today.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-june-20th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!



Moving stocks are a bankruptcy filing, regulator approval, a public offering and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Spectaire (NASDAQ:<a href="https://investorplace.com/stock-quotes/spec-stock-quote/">SPEC</a>) stock is rocketing more than 111% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318405643&amp;type=PDF&amp;symbol=SPEC&amp;cdn=402f87b97cb330efbad1632693edb216&amp;companyName=Spectaire+Holdings+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-20">letter, settlement and asset purchase agreements</a>.</li>



<li>Trinity Place (NYSEMKT:<a href="https://investorplace.com/stock-quotes/tphs-stock-quote/">TPHS</a>) shares are soaring over 52% with heavy pre-market trading today.</li>



<li>DermTech (NASDAQ:<a href="https://investorplace.com/stock-quotes/dmtk-stock-quote/">DMTK</a>) stock is surging more than 45% <a href="https://finance.yahoo.com/news/dermtech-files-voluntary-chapter-11-120500056.html">despite a recent bankruptcy filing</a>.</li>



<li>Sarepta Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/srpt-stock-quote/">SRPT</a>) shares are gaining over 37% on <a href="https://www.marketwatch.com/story/sarepta-shares-soar-37-following-expanded-approval-for-elevidys-991d6de5?mod=home-page">expanded regulator approval</a>.</li>



<li>Kintara Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ktra-stock-quote/">KTRA</a>) stock is increasing 27% with strong early morning trading.</li>



<li>Qualigen Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/qlgn-stock-quote/">QLGN</a>) shares are rising more than 16% with heavy trading today.</li>



<li>Unusual Machines (NYSEMKT:<a href="https://investorplace.com/stock-quotes/umac-stock-quote/">UMAC</a>) stock is climbing close to 16% despite a lack of news today.</li>



<li>Simpple (NASDAQ:<a href="https://investorplace.com/stock-quotes/sppl-stock-quote/">SPPL</a>) shares are jumping nearly 15% without any clear news today.</li>



<li>Lion Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/lghl-stock-quote/">LGHL</a>) stock is heading over 13% higher on Friday morning.</li>



<li>Solid Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/sldb-stock-quote/">SLDB</a>) shares are up more than 13% without any news to report.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Abacus Life (NASDAQ:<a href="https://investorplace.com/stock-quotes/abl-stock-quote/">ABL</a>) stock is diving over 23% after <a href="https://www.nasdaq.com/press-release/abacus-life-announces-pricing-public-offering-common-stock-2024-06-20">pricing a public offering</a>.</li>



<li>Psyence Biomedical (NASDAQ:<a href="https://investorplace.com/stock-quotes/pbm-stock-quote/">PBM</a>) shares are tumbling 20% on Friday morning.</li>



<li>Professional Diversity (NASDAQ:<a href="https://investorplace.com/stock-quotes/ipdn-stock-quote/">IPDN</a>) stock is taking a more than 18% beating with strong early morning trading.</li>



<li>Kaival Brands Innovations (NASDAQ:<a href="https://investorplace.com/stock-quotes/kavl-stock-quote/">KAVL</a>) shares are sliding over 17% on Friday morning.</li>



<li>QXO (NASDAQ:<a href="https://investorplace.com/stock-quotes/qxo-stock-quote/">QXO</a>) stock is dropping 16% today.</li>



<li>Reliance Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/reli-stock-quote/">RELI</a>) shares are falling more than 15% <a href="https://investorplace.com/2024/06/why-is-reliance-global-reli-stock-up-283-today/">after a recent rally</a>.</li>



<li>MGO Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/mgol-stock-quote/">MGOL</a>) stock is retreating over 14% <a href="https://investorplace.com/2024/06/why-is-mgo-global-mgol-stock-up-133-today/">following a rally yesterday</a>.</li>



<li>Cyclerion Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cycn-stock-quote/">CYCN</a>) shares are decreasing 14% this morning.</li>



<li>Perfect (NYSE:<a href="https://investorplace.com/stock-quotes/perf-stock-quote/">PERF</a>) stock is slipping more than 12% today.</li>



<li>Scinai Immunotherapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/scni-stock-quote/">SCNI</a>) shares close out our pre-market stock movers down over 11% today.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-june-21st/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Kaival Brands dips on announcing the pricing of its $6 million offering

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Kaival Brands Innovations (NASDAQ:<a href="https://investorplace.com/stock-quotes/kavl-stock-quote/">KAVL</a>) just reported results for the second quarter of 2024.<ul><li>Kaival Brands Innovations reported earnings per share of -56 cents.</li><li>The company reported revenue of $2.23 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/06/kavl-stock-earnings-kaival-brands-innovations-for-q2-of-2024/">KAVL Stock Earnings: Kaival Brands Innovations Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

KAVL Stock Earnings: Kaival Brands Innovations Reported Results for Q2 2024

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning!



Moving stocks this morning are earnings reports, insider buying, offerings and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Volcon (NASDAQ:<a href="https://investorplace.com/stock-quotes/vlcn-stock-quote/">VLCN</a>) stock is rocketing more than 78% alongside heavy pre-market trading.</li>



<li>Senti Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/snti-stock-quote/">SNTI</a>) shares are soaring over 47% with strong early morning trading.</li>



<li>GlycoMimetics (NASDAQ:<a href="https://investorplace.com/stock-quotes/glyc-stock-quote/">GLYC</a>) stock is surging more than 39% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318411360&amp;type=PDF&amp;symbol=GLYC&amp;cdn=8f7645b9da4ce31c36360d7737c007dc&amp;companyName=GlycoMimetics+Inc.&amp;formType=4&amp;formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2024-06-24">alongside insider buying</a>.</li>



<li>Anew Medical (OTCMKTS:<a href="https://investorplace.com/stock-quotes/leas-stock-quote/">LEAS</a>) shares are gaining over 38% without any clear news this morning.</li>



<li>Nukkleus (NASDAQ:<a href="https://investorplace.com/stock-quotes/nukk-stock-quote/">NUKK</a>) shares are increasing more than 24% with strong pre-market trading.</li>



<li>Regis (NASDAQ:<a href="https://investorplace.com/stock-quotes/rgs-stock-quote/">RGS</a>) stock is rising over 21% after announcing a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318412499&amp;type=PDF&amp;symbol=RGS&amp;cdn=4f01bbb678bba4ddafaac79f77ec0544&amp;companyName=Regis+Corporation&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-25">senior secured credit facility</a>.</li>



<li>Netcapital (NASDAQ:<a href="https://investorplace.com/stock-quotes/ncpl-stock-quote/">NCPL</a>) shares are heading close to 20% higher with heavy pre-market trading today.</li>



<li>Kaival Brands Innovations (NASDAQ:<a href="https://investorplace.com/stock-quotes/kavl-stock-quote/">KAVL</a>) stock is jumping more than 17% <a href="https://www.nasdaq.com/press-release/kaival-brands-announces-closing-60-million-public-offering-2024-06-24">after closing a public offering</a>.</li>



<li>BioXcel Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/btai-stock-quote/">BTAI</a>) shares are climbing over 13% on <a href="https://www.nasdaq.com/press-release/bioxcel-therapeutics-announces-positive-topline-results-post-marketing-requirement">topline results from a study</a>.</li>



<li>Captivision (NASDAQ:<a href="https://investorplace.com/stock-quotes/capt-stock-quote/">CAPT</a>) stock is up more than 12% on Tuesday morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Faraday Future (NASDAQ:<a href="https://investorplace.com/stock-quotes/ffie-stock-quote/">FFIE</a>) stock is plummeting over 25% on plans for a <a href="https://finance.yahoo.com/news/faraday-future-announces-plans-regaining-215900667.html">reverse stock split</a>.</li>



<li>Concord Medical Services (NYSE:<a href="https://investorplace.com/stock-quotes/ccm-stock-quote/">CCM</a>) shares are diving more than 22% after a massive rally yesterday.</li>



<li>Beyond Air (NASDAQ:<a href="https://investorplace.com/stock-quotes/xair-stock-quote/">XAIR</a>) stock is tumbling over 19% on <a href="https://finance.yahoo.com/news/beyond-air-inc-xair-reports-212503389.html">lackluster Q4 earnings</a>.</li>



<li>MicroAlgo (NASDAQ:<a href="https://investorplace.com/stock-quotes/mlgo-stock-quote/">MLGO</a>) shares are retreating more than 19% <a href="https://investorplace.com/2024/06/why-is-microalgo-mlgo-stock-up-113-today/">after rallying yesterday</a>.</li>



<li>SolarEdge Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/sedg-stock-quote/">SEDG</a>) stock is taking an over 16% beating on a <a href="https://www.nasdaq.com/press-release/solaredge-technologies-inc-announces-proposed-private-offering-300-million">$300 million private offering</a>.</li>



<li>IGC Pharma (NYSEMKT:<a href="https://investorplace.com/stock-quotes/igc-stock-quote/">IGC</a>) shares are dropping more than 16% on its <a href="https://www.nasdaq.com/press-release/igc-reports-financial-results-fiscal-year-ended-march-31-2024-2024-06-24">latest earnings report</a>.</li>



<li>Oragenics (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ogen-stock-quote/">OGEN</a>) stock is falling over 15% on a <a href="https://www.stocktitan.net/news/OGEN/oragenics-inc-announces-proposed-public-688vwqnwez4o.html">proposed public offering</a>.</li>



<li>DermTech (NASDAQ:<a href="https://investorplace.com/stock-quotes/dmtk-stock-quote/">DMTK</a>) shares are decreasing nearly 12% after a <a href="https://www.nasdaq.com/press-release/dermtech-files-voluntary-chapter-11-protection-2024-06-18">recent bankruptcy filing</a>.</li>



<li>Professional Diversity (NASDAQ:<a href="https://investorplace.com/stock-quotes/ipdn-stock-quote/">IPDN</a>) stock is slipping more than 11% with recent weakness.</li>



<li>36KR (NASDAQ:<a href="https://investorplace.com/stock-quotes/krkr-stock-quote/">KRKR</a>) shares close out our pre-market stock movers down over 10%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-june-25th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Kaival Brands Innovations Group ( ($KAVL) ) has provided an announcement. Mark Thoenes has been appointed as the interim CEO of Kaival Brands Innov...

Kaival Brands Appoints Mark Thoenes as Interim CEO

Kaival Brands Innovations Group ( ($KAVL) ) has issued an update. Kaival Brands Innovations Group, Inc. has announced a major step forward with a M...

Kaival Brands Announces Strategic Merger with Delta Corp

The latest update is out from Kaival Brands Innovations Group ( ($KAVL) ). The Company has entered into a consulting agreement with Interim CEO Mar...

Kaival Brands Aligns Leadership with Shareholder Interests

ASLN

ASNS

AVRO

BTAI

CAPT

CYCN

DECA

DMTK

EFSH

FFIE

GLYC

HUIZ

IPDN

KRKR

KTRA

LEAS

LGHL

LRHC

MBIO

MGOL

MLGO

MOLN

NCPL

NDRA

NITO

NLSP

NUKK

OGEN

PERF

PRST

QLGN

RELI

SCNI

SEDG

SHMD

SLDB

SNTI

SPEC

SPPL

SRPT

TLPH

TPHS

TPST

UMAC

VLCN

XAIR

Press Releases

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SMAR, MKFG, KAVL, ITI on Behalf of Shareholders

Delta Corp Holdings Limited Advances Business Combination With Kaival Brands Innovations Group, Inc. With Confidential Submission of Draft Registration Statement With the Securities and Exchange Commission

Kuehn Law Encourages FYBR, CHUY, KAVL, and GABC Investors to Contact Law Firm

KAIVAL BRANDS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Kaival Brands Innovations Group, Inc. - KAVL

Legal

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FYBR, CHUY, KAVL, GABC on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTTR, MKFG, KAVL on Behalf of Shareholders

Kuehn Law Encourages COFS, KAVL, FYBR, and RFL Investors to Contact Law Firm

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SMAR, KAVL, SMC on Behalf of Shareholders

NASDAQ Stocks Under $1 to Watch in October 2024: LGCB, KAVL, NXL, NXU, FAMI

Power Nickel Announces Major Copper Discovery as Gold Hits Historic High more stocks inside….

Comments

Kaival Brands Innovations

Kaival Brands Innovations (KAVL) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga